✦ LIBER ✦

Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma

✍ Scribed by J. F. de Groot; M. R. Gilbert; K. Aldape; K. R. Hess; T. A. Hanna; S. Ictech; M. D. Groves; C. Conrad; H. Colman; V. K. Puduvalli; V. Levin; W. K. A. Yung

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 255 KB
Volume: 90
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-008-9637-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose-escalation and bioavailab

A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin

✍ M. Ranson; H. Shaw; J. Wolf; M. Hamilton; S. McCarthy; E. Dean; A. Reid; I. Juds 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 340 KB

Carboplatin and teniposide concurrent wi

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme : A Phase II Study

✍ Alba A. Brandes; Alberto Rigon; Paolo Zampieri; Mario Ermani; Carla Carollo; Giu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The outcome after treatment for glioblastoma remains poor

Phase II trial of erlotinib with temozol

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

✍ David M. Peereboom; Dale R. Shepard; Manmeet S. Ahluwalia; Cathy J. Brewer; Neer 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 180 KB

Phase I and pharmacokinetic study of erl

Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)

✍ Eric H. Kraut; Christopher Rhoades; Yilong Zhang; Hao Cheng; Josephine Aimiumu; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

A phase II study of carboplatin and chro

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma

✍ P. Tang; G. Roldan; P.M.A Brasher; D. Fulton; W. Roa; A. Murtha; J.G. Cairncross 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 195 KB

Phase II study of carboplatin and liposo

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix

✍ Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti